diabetics
Clinical Trials Begin For New Diabetes Drug
Filed in archive Treatment by Rhys on July 31, 2006
Clinical Trials Begin For New Diabetes Drug
It seems that diabetes research and treatment inventions never slow down. Which could be considered a good thing, both by patients who may benefit from them, and by the pharmaceutical companies who pocket big bucks from them.

Yet another diabetes medication is on the horizon, an oral treatment designed to treat Type 2. Researchers believe the medicine is an innovation in diabetes treatment.

The mechanism of action of DPP-4 inhibitors is distinct from that of any currently available class of glucose lowering agents.

Sitagliptin is a potent and highly selective DPP-4 inhibitor. DPP-4 inhibitors work by enhancing a natural body process that lowers blood sugar, the incretin system. When blood sugar is elevated, incretins work in two ways to help the body regulate high blood sugar levels: they trigger the pancreas to increase insulin and signal the liver to stop producing glucose.


Would you be willing to try it?

Permalink: Clinical Trials Begin For New Diabetes Drug
Tags: diabetes+treatment  diabetes  treatment  drug  trials  diabetes+drug  begin+diabetes  trials+begin 
Trackback: http://publish.creative-weblogging.com/publish/mt-tb.pl/31317
img Addthis img Ask img Blinklist img del.icio.us img Digg img Fark img Facebook img Google img Lycos img Ma.gnolia Add this page to Mister Wong Mr Wong img Netscape img Netvousz img Newsvine img Reddit img StumbleUpon img Slashdot img Tailrank img Technorati img Wink img Yahoo

Vote for Clinical Trials Begin For New Diabetes Drug:

  • Currently 9.00/10
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
Rating: 9.00 out of 3 vote(s) cast.
 
Subscribe
Share It
RSSrss
See all blog subscribe options
Google google
What is RSS?
Yahoo! yahoo
Addthis Subscribe using any feed reader!
Bloglines Bloglines
Newsletter

TwitterFollow us on Twitter!